EPHA2 and breast carcinoma: Although EphA2 receptor tyrosine kinase plays a crucial, clinically relevant role in breast cancer growth across multiple subtypes and in visceral metastasis,23, 24, 25, 26, 28, 29, 30 its role in breast‐to‐bone metastasis remains unclear.